Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

N‐acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double‐blind, placebo‐controlled trial

N‐acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Arthritis & Rheumatology Wiley

N‐acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double‐blind, placebo‐controlled trial

Loading next page...
 
/lp/wiley/n-acetylcysteine-reduces-disease-activity-by-blocking-mammalian-target-lyAFt0SrXt

References (33)

Publisher
Wiley
Copyright
Copyright © 2012 Wiley Subscription Services, Inc., A Wiley Company
ISSN
2326-5191
eISSN
2326-5205
DOI
10.1002/art.34502
Publisher site
See Article on Publisher Site

Abstract

Journal

Arthritis & RheumatologyWiley

Published: Sep 1, 2012

There are no references for this article.